⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17542246 | 1.00 | — | — | |
| SCHEMBL548843 | 1.00 | — | — | |
| SCHEMBL13978920 | 0.76 | — | — | |
| SCHEMBL8322115 | 0.76 | — | — | |
| SCHEMBL2153981 | 0.75 | — | — | |
| SCHEMBL2614303 | 0.75 | TP53 (0.32) | — | |
| SCHEMBL675611 | 0.75 | — | — | |
| SCHEMBL790603 | 0.75 | — | — | |
| SCHEMBL4584154 | 0.75 | TP53 (0.32) | — | |
| SCHEMBL12808547 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108929267-B | Quinolone skeleton and synthesis method thereof | 中南大学 | 2021-07-02 | — | — | CN | claimed |
| EP-3455200-A1 | PROCESS FOR PRODUCTION OF MIXED 2,2-DIALKYL-1,3-PROPANEDIOLS | Perstorp AB (SE) | 2019-03-20 | — | — | EP | claimed |
| WO-2017196225-A1 | PROCESS FOR PRODUCTION OF MIXED 2,2-DIALKYL-1,3-PROPANEDIOLS | PERSTORP AB (SE) | 2017-11-16 | — | — | WO | claimed |
| WO-2016042172-A1 | IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS | ACTIVE BIOTECH AB (SE) | 2016-03-24 | — | — | WO | claimed |
| CN-103664591-A | Novel benzendiol derivative compound and cosmetic composition utilizing the same | ACT CO LTD | 2014-03-26 | — | — | CN | claimed |
| US-8486892-B2 | Blood coagulation factor inhibitors | NOVO NORDISK HEALTH CARE AG (CH) | 2013-07-16 | — | — | US | claimed |
| EP-1799729-B1 | FUNCTIONAL SILOXANES AND THEIR VINYL CO-POLYMERS | HONEYWELL INT INC (US) | 2012-10-17 | — | — | EP | claimed |
| CN-101981050-A | New blood coagulation factor inhibitors | NOVO NORDISK HEALTHCARE AG | 2011-02-23 | — | — | CN | claimed |
| US-20110003752-A1 | New Blood Coagulation Factor Inhibitors | NOVO NORDISK HEALTH CARE A/G (CH) | 2011-01-06 | — | — | US | claimed |
| EP-2235042-A1 | NEW BLOOD COAGULATION FACTOR INHIBITORS | Novo Nordisk Health Care AG (CH) | 2010-10-06 | — | — | EP | claimed |
| WO-2009092758-A1 | NEW BLOOD COAGULATION FACTOR INHIBITORS | NOVO NORDISK HEALTH CARE AG (DK) | 2009-07-30 | — | — | WO | claimed |
| CN-101010355-A | Functionalized siloxanes and silanes and their vinyl copolymers | HONEYWELL INT INC (US) | 2007-08-01 | — | — | CN | claimed |
| EP-1799729-A1 | FUNCTIONAL SILOXANES AND SILANES AND THEIR VINYL CO-POLYMERS | Honeywell International, Inc. (US) | 2007-06-27 | — | — | EP | claimed |
| WO-2006014328-A1 | FUNCTIONAL SILOXANES AND SILANES AND THEIR VINYL CO-POLYMERS | HONEYWELL INTERNATIONAL INC. (US) | 2006-02-09 | — | — | WO | claimed |
| EP-1098699-B1 | PRODUCTION OF GLYCOL MONOESTER | EASTMAN CHEM CO (US) | 2003-05-14 | — | — | EP | claimed |
| JP-2002519274-A | — | — | 2002-07-02 | — | — | JP | claimed |
| EP-1098699-A1 | BASIC CLAY CATALYST FOR THE PRODUCTION OF GLYCOL MONOESTER | EASTMAN CHEMICAL COMPANY (US) | 2001-05-16 | — | — | EP | claimed |
| US-6215020-B1 | COMPRISING HEATING IN A REACTION VESSEL AN ALDEHYDE AND A CATALYTIC AMOUNT OF A BASE-MODIFIED CLAY, TO PRODUCE A GLYCOL MONOESTER | EASTMAN CHEMICAL COMPANY | 2001-04-10 | — | — | US | claimed |
| WO-2000000282-A1 | BASIC CLAY CATALYST FOR THE PRODUCTION OF GLYCOL MONOESTER | EASTMAN CHEMICAL COMPANY (US) | 2000-01-06 | — | — | WO | claimed |
| WO-2000000456-A1 | PREPARATION OF AN ALDOL USING A BASE-MODIFIED CLAY CATALYST | EASTMAN CHEMICAL COMPANY (US) | 2000-01-06 | — | — | WO | claimed |